Intuitive Surgical (NASDAQ:ISRG) was downgraded by equities researchers at BidaskClub from a “buy” rating to a “hold” rating in a report issued on Tuesday, BidAskClub reports.

Other equities analysts have also issued research reports about the stock. ValuEngine lowered shares of Intuitive Surgical from a “hold” rating to a “sell” rating in a report on Friday, July 12th. Canaccord Genuity restated a “buy” rating and issued a $610.00 target price (up previously from $575.00) on shares of Intuitive Surgical in a report on Friday, July 19th. Northland Securities set a $375.00 target price on shares of Intuitive Surgical and gave the stock a “sell” rating in a report on Friday, July 19th. UBS Group set a $560.00 target price on shares of Intuitive Surgical and gave the stock a “hold” rating in a report on Friday, July 19th. Finally, Raymond James lowered their target price on shares of Intuitive Surgical from $630.00 to $610.00 and set an “outperform” rating on the stock in a report on Monday, April 22nd. Three equities research analysts have rated the stock with a sell rating, four have assigned a hold rating and nine have assigned a buy rating to the stock. The stock currently has an average rating of “Hold” and a consensus price target of $579.92.

Shares of NASDAQ ISRG opened at $501.28 on Tuesday. The firm’s 50-day moving average price is $520.69 and its 200-day moving average price is $525.57. Intuitive Surgical has a 1-year low of $430.24 and a 1-year high of $589.32. The firm has a market capitalization of $57.10 billion, a P/E ratio of 52.82, a P/E/G ratio of 3.68 and a beta of 1.12.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings data on Thursday, July 18th. The medical equipment provider reported $3.25 earnings per share for the quarter, beating the consensus estimate of $2.23 by $1.02. Intuitive Surgical had a net margin of 29.95% and a return on equity of 17.35%. The firm had revenue of $1.10 billion for the quarter, compared to analyst estimates of $1.03 billion. During the same quarter in the prior year, the business earned $2.76 earnings per share. The business’s quarterly revenue was up 20.9% compared to the same quarter last year. Sell-side analysts forecast that Intuitive Surgical will post 10.15 earnings per share for the current fiscal year.

In other Intuitive Surgical news, Director Lonnie M. Smith sold 215 shares of the company’s stock in a transaction dated Tuesday, August 20th. The shares were sold at an average price of $493.18, for a total value of $106,033.70. Following the completion of the sale, the director now directly owns 330,868 shares of the company’s stock, valued at approximately $163,177,480.24. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, VP Jamie Samath sold 130 shares of the company’s stock in a transaction dated Monday, June 10th. The stock was sold at an average price of $500.60, for a total transaction of $65,078.00. Following the completion of the sale, the vice president now directly owns 219 shares of the company’s stock, valued at $109,631.40. The disclosure for this sale can be found here. Insiders sold a total of 26,000 shares of company stock valued at $13,724,409 over the last ninety days. 1.70% of the stock is currently owned by insiders.

Hedge funds have recently modified their holdings of the business. Buffington Mohr McNeal bought a new stake in Intuitive Surgical in the 1st quarter worth about $86,000. Burns J W & Co. Inc. NY grew its position in Intuitive Surgical by 28.2% in the 2nd quarter. Burns J W & Co. Inc. NY now owns 1,497 shares of the medical equipment provider’s stock worth $785,000 after purchasing an additional 329 shares in the last quarter. ARK Investment Management LLC grew its position in Intuitive Surgical by 10.3% in the 2nd quarter. ARK Investment Management LLC now owns 5,434 shares of the medical equipment provider’s stock worth $2,850,000 after purchasing an additional 508 shares in the last quarter. HCR Wealth Advisors grew its position in shares of Intuitive Surgical by 19.6% during the 2nd quarter. HCR Wealth Advisors now owns 532 shares of the medical equipment provider’s stock valued at $279,000 after acquiring an additional 87 shares during the period. Finally, Birinyi Associates Inc. bought a new position in shares of Intuitive Surgical during the 2nd quarter valued at approximately $787,000. 86.12% of the stock is owned by institutional investors and hedge funds.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc designs, manufactures, and markets da Vinci surgical systems, and related instruments and accessories. Its da Vinci Surgical System transforms the surgeon's natural hand movements outside the body into corresponding micro-movements inside the patient's body. The company's da Vinci Surgical System include surgeon's consoles, patient-side carts, 3-D vision systems, da Vinci skills simulators, da Vinci Xi integrated table motions, and Firefly fluorescence imaging products that enable surgeons to perform various surgical procedures, including gynecologic, urologic, general, cardiothoracic, and head and neck surgical procedures.

Featured Story: Oversold

Analyst Recommendations for Intuitive Surgical (NASDAQ:ISRG)

Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.